📰 Exact Sciences News
Page 21 - Exact Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Exact Sciences. Real-time updates on events, politics, business and more.
December 8, 2023
Scientists and entrepreneurs in the country are exploring ways to replace plastic packaging with everyday materials
December 7, 2023
This retrospective cohort study assesses the cumulative incidence of pregnancy after cancer and disease-free survival in BRCA carriers diagnosed with invasive b
December 7, 2023
/PRNewswire/ -- Exact Sciences, a leading provider of cancer screening and diagnostic tests, announced today that it awarded $1.3 million to 23 organizations...
December 7, 2023
In vitro diagnostics players are being tested as their offerings are increasingly commoditized. Digital diagnostics offers a path to growth.
December 6, 2023
For patients whose breast cancer converted from lymph node-positive to lymph node-negative disease after neoadjuvant chemotherapy, skipping adjuvant regional nodal irradiation (RNI) did not increase the risk of disease recurrence or death five years after surgery, according to results from the NRG Oncology/NSABP B-51/RTOG 1304 clinical trial presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.
December 5, 2023
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here.
December 5, 2023
Align Technology, Inc. today announced that its Board of Directors has appointed Mojdeh Poul, former EVP and Group President of 3M Health Care, and Kevin Conroy, President, Chief Executive Officer,...
December 4, 2023
In this sixth episode of OncChats: Assessing the Promise of AI in Oncology, Toufic A. Kachaamy, MD, and Douglas Flora, MD, LSSBB, FACCC, discuss potential opportunities to leverage artificial intelligence tools in cancer screening, diagnosis, staging, and prognosis.
December 1, 2023
More than 10% of fecal immunochemical tests (FIT) have unusable samples putting people at risk for missing early cancer markers. FIT looks for blood in the stool and is different from Cologuard, which checks for blood and DNA markers.
December 1, 2023
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here.